Benitec Biopharma Inc.

Healthcare

NASDAQ:BNTC · NASDAQ Capital Market

Market Cap $293.44M Beta 0.28 P/E (TTM) -11.3

$11.10 +1.18%

+$0.13 today

52W Low $9.85High $17.10

Vol 0.08M · Avg 0.11M

EPS (TTM) -$0.99Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-28.11%

Period High

$16.52

Period Low

$10.06

Latest

$11.10

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Solid Biosciences Inc.

NASDAQ:SLDB

$556.28M

XOMA Royalty Corp.

NASDAQ:XOMA

$524.09M

Neurogene Inc.

NASDAQ:NGNE

$459.84M

PureTech Health plc

NASDAQ:PRTC

$424.07M

Autolus Therapeutics plc

NASDAQ:AUTL

$415.18M

Ocugen, Inc.

NASDAQ:OCGN

$409.61M

Lineage Cell Therapeutics, Inc.

AMEX:LCTX

$316.61M

I-Mab

IMAB

$235.66M

Quantum-Si incorporated

NASDAQ:QSI

$187.28M

Galectin Therapeutics Inc.

NASDAQ:GALT

$175.84M

What is the latest BNTC filing?

The latest filing shown is 8-K dated May 29, 2026.

How many recent filings does BNTC have?

Intrinsic Alpha currently shows 20 recent filings for BNTC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.